Broad Institute of MIT and Harvard
Stanley Center for Psychiatric Research
Du Bois Research Group
B.S., Chemistry (major) and Biology (minor)
Kehlbeck Research Group
The interface of chemistry and biology has always been the focus of David's scientific interests. As an undergraduate at Union College, he worked with Joanne Kehlbeck on the design, synthesis, and evaluation of molecular transporters for drug delivery. He then took a position at Albany Molecular Research, Inc. before attending Stanford University for graduate school. While at Stanford, David worked with Justin Du Bois to develop several Rh-catalzyed oxidative amination methods for the synthesis of diamines and polyamines. Additionally, they made significant progress towards the total synthesis of pactamycin, arguably the most densely functionalized aminocyclitol known. In 2011, David took a postdoctoral position in the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard. Under the mentorship of Steve Hyman, David studied the role of small molecules in treating neurodegenerative diseases and helped characterize several animal models of psychiatric disorders. He joined the faculty at UC Davis in 2015.
Having received highly interdisciplinary training encompassing synthetic chemistry as well as molecular, cellular, and behavioral neuroscience, David remains a strong believer in the power of using synthesis to answer outstanding questions in neurobiology.